Embecta EMBC
NASDAQ EMBC
$5.23 -0.24 (-4.39%)
At close: Aug 21, 2026 · 4:00 PM EDT

Embecta (EMBC) Liabilities and Shareholders Equity (2021 - 2026)

Embecta (EMBC) posted Liabilities and Shareholders Equity of $1.0 billion for Q1 2026, down 3.23% sequentially from $1.1 billion in Q4 2025, and down 8.11% YoY from $1.1 billion in Q1 2025.

Embecta (EMBC) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends

Embecta has reported Liabilities and Shareholders Equity for 6 years, with the latest figure at $1.0 billion in Q1 2026.

  • Quarterly Liabilities and Shareholders Equity fell 8.11% year-over-year to $1.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.3 billion (down 9.98% YoY) and the FY2025 annual result came in at $1.1 billion, down 15.12% from the prior year.
  • Liabilities and Shareholders Equity declined to $1.0 billion in Q1 2026 per EMBC's latest filing, from $1.1 billion in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $1.3 billion in Q3 2024 and troughed at $833.5 million in Q1 2022.
  • A 5-year average of $1.1 billion and a median of $1.2 billion in 2025 frame the typical range for Liabilities and Shareholders Equity.
  • The sharpest annual moves came in 2022 and 2025: Liabilities and Shareholders Equity jumped 61.77% in 2022, then decreased 15.12% in 2025.
  • Over 5 years, Liabilities and Shareholders Equity stood at $1.2 billion in 2022, then gained by 1.75% to $1.2 billion in 2023, then declined by 5.61% to $1.1 billion in 2024, then retreated by 7.46% to $1.1 billion in 2025, then slipped by 3.23% to $1.0 billion in 2026.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $1.0 billion, $1.1 billion, and $1.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn 20.88 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn 50.73 Bn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn 31.10 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn 8.97 Bn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn 39.35 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn 4.08 Bn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn 14.24 Bn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn 12.48 Bn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn 19.79 Bn
10 Embecta 305.26 Mn 87.06 Mn 153.30 Mn 1.27 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.27 Bn
Mar 31, 2026 1.03 Bn
Dec 31, 2025 1.06 Bn
Sep 30, 2025 1.09 Bn
Jun 30, 2025 1.16 Bn
Mar 31, 2025 1.12 Bn
Dec 31, 2024 1.15 Bn
Sep 30, 2024 1.29 Bn
Jun 30, 2024 1.27 Bn
Mar 31, 2024 1.20 Bn
Dec 31, 2023 1.22 Bn
Sep 30, 2023 1.21 Bn
Jun 30, 2023 1.25 Bn
Mar 31, 2023 1.21 Bn
Dec 31, 2022 1.20 Bn
Sep 30, 2022 1.09 Bn
Jun 30, 2022 1.05 Bn
Mar 31, 2022 833.50 Mn
Dec 31, 2021 739.90 Mn
Sep 30, 2021 788.00 Mn